APO Research, Inc.

APO RESEARCH · REPORT

Food Allergy Therapeutics

Selected research

Market Analysis & Forecast

Global Food Allergy Therapeutics Market Analysis and Forecast 2026-2032

Market perspective

The global Food Allergy Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Food Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Food Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Food Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Food Allergy Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Food Allergy Therapeutics include Aimmune Therapeutics, ALK Abello, Amneal Pharma, HUAPONT Pharm, Kaleo, Perrigo, UCB Pharma, Viatris and Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Food Allergy Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Food Allergy Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Food Allergy Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Food Allergy Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Food Allergy Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Food Allergy Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Food Allergy Therapeutics Segment by Company

Aimmune Therapeutics

ALK Abello

Amneal Pharma

HUAPONT Pharm

Kaleo

Perrigo

UCB Pharma

Viatris

Bayer

GSK

J & J

Food Allergy Therapeutics Segment by Type

Epinephrine Injection

Antihistamines

Other

Food Allergy Therapeutics Segment by Application

Hospital Pharmacy

Retail Pharmacy

Other

Food Allergy Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Food Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Food Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Food Allergy Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Food Allergy Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Food Allergy Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Food Allergy Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Food Allergy Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Epinephrine Injection Major Player Table 3. Antihistamines Major Player Table 4. Other Major Player Table 5. Global Food Allergy Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacy Major Player Table 7. Retail Pharmacy Major Player Table 8. Other Major Player Table 9. Food Allergy Therapeutics Industry Trends Table 10. Food Allergy Therapeutics Industry Drivers Table 11. Food Allergy Therapeutics Industry Opportunities and Challenges Table 12. Food Allergy Therapeutics Industry Restraints Table 13. Global Food Allergy Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Food Allergy Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Food Allergy Therapeutics Market Share by Region (2021-2026) Table 16. Global Food Allergy Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Food Allergy Therapeutics Market Share by Region (2027-2032) Table 18. Global Food Allergy Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Food Allergy Therapeutics Revenue Market Share by Players (2021-2026) Table 20. Global Food Allergy Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Food Allergy Therapeutics Key Players Headquarters & Area Served Table 22. Global Food Allergy Therapeutics Players, Product Type & Application Table 23. Global Food Allergy Therapeutics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Food Allergy Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Food Allergy Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Food Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Food Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Food Allergy Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Food Allergy Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Food Allergy Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Food Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Food Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Food Allergy Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Food Allergy Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Aimmune Therapeutics Company Information Table 37. Aimmune Therapeutics Business Overview Table 38. Aimmune Therapeutics Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Aimmune Therapeutics Food Allergy Therapeutics Product Portfolio Table 40. Aimmune Therapeutics Recent Development Table 41. ALK Abello Company Information Table 42. ALK Abello Business Overview Table 43. ALK Abello Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. ALK Abello Food Allergy Therapeutics Product Portfolio Table 45. ALK Abello Recent Development Table 46. Amneal Pharma Company Information Table 47. Amneal Pharma Business Overview Table 48. Amneal Pharma Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Amneal Pharma Food Allergy Therapeutics Product Portfolio Table 50. Amneal Pharma Recent Development Table 51. HUAPONT Pharm Company Information Table 52. HUAPONT Pharm Business Overview Table 53. HUAPONT Pharm Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. HUAPONT Pharm Food Allergy Therapeutics Product Portfolio Table 55. HUAPONT Pharm Recent Development Table 56. Kaleo Company Information Table 57. Kaleo Business Overview Table 58. Kaleo Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Kaleo Food Allergy Therapeutics Product Portfolio Table 60. Kaleo Recent Development Table 61. Perrigo Company Information Table 62. Perrigo Business Overview Table 63. Perrigo Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Perrigo Food Allergy Therapeutics Product Portfolio Table 65. Perrigo Recent Development Table 66. UCB Pharma Company Information Table 67. UCB Pharma Business Overview Table 68. UCB Pharma Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. UCB Pharma Food Allergy Therapeutics Product Portfolio Table 70. UCB Pharma Recent Development Table 71. Viatris Company Information Table 72. Viatris Business Overview Table 73. Viatris Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Viatris Food Allergy Therapeutics Product Portfolio Table 75. Viatris Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bayer Food Allergy Therapeutics Product Portfolio Table 80. Bayer Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Food Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. GSK Food Allergy Therapeutics Product Portfolio Table 85. GSK Recent Development Table 86. J & J Company Information Table 87. J & J Business Overview Table 88. J & J Food Allergy Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. J & J Food Allergy Therapeutics Product Portfolio Table 90. J & J Recent Development Table 91. North America Food Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Food Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Food Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Food Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Food Allergy Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Food Allergy Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Food Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Food Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Food Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Food Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Food Allergy Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Food Allergy Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 105. China Food Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 106. China Food Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 107. China Food Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 108. China Food Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Food Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Food Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Food Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Food Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Food Allergy Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Food Allergy Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Food Allergy Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Food Allergy Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Food Allergy Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Food Allergy Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Food Allergy Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Food Allergy Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Food Allergy Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Food Allergy Therapeutics Image Figure 2. Global Food Allergy Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Food Allergy Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Epinephrine Injection Image Figure 5. Antihistamines Image Figure 6. Other Image Figure 7. Global Food Allergy Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Food Allergy Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Other Image Figure 12. Global Food Allergy Therapeutics Market Size (US$ Million) & (2021-2032) Figure 13. Global Food Allergy Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Food Allergy Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Food Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Food Allergy Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Food Allergy Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Food Allergy Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Food Allergy Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Food Allergy Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Food Allergy Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Food Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Food Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 25. North America Food Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 26. North America Food Allergy Therapeutics Revenue Share by Country (2021-2032) Figure 27. United States Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Food Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Food Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 32. Europe Food Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 33. Europe Food Allergy Therapeutics Revenue Share by Country (2021-2032) Figure 34. Germany Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Food Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Food Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 44. China Food Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 45. Asia Food Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Food Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 47. Asia Food Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Food Allergy Therapeutics Revenue Share by Region (2021-2032) Figure 49. Japan Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Food Allergy Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Food Allergy Therapeutics Revenue Share by Type (2021-2032) Figure 57. SAMEA Food Allergy Therapeutics Revenue Share by Application (2021-2032) Figure 58. SAMEA Food Allergy Therapeutics Revenue Share by Country (2021-2032) Figure 59. Brazil Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Food Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Epinephrine Injection
  • Antihistamines
  • Other
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
Companies covered
  • Aimmune Therapeutics
  • ALK Abello
  • Amneal Pharma
  • HUAPONT Pharm
  • Kaleo
  • Perrigo
  • UCB Pharma
  • Viatris
  • Bayer
  • GSK
  • J & J

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Food Allergy Therapeutics Market by Type
  3. 1.2.1 Global Food Allergy Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Epinephrine Injection
  5. 1.2.3 Antihistamines
  6. 1.2.4 Other
  7. 1.3 Food Allergy Therapeutics Market by Application
  8. 1.3.1 Global Food Allergy Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacy
  10. 1.3.3 Retail Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Food Allergy Therapeutics Market Dynamics
  1. 2.1 Food Allergy Therapeutics Industry Trends
  2. 2.2 Food Allergy Therapeutics Industry Drivers
  3. 2.3 Food Allergy Therapeutics Industry Opportunities and Challenges
  4. 2.4 Food Allergy Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Food Allergy Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Food Allergy Therapeutics Growth Trends by Region
  3. 3.2.1 Global Food Allergy Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Food Allergy Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Food Allergy Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Food Allergy Therapeutics Revenue by Players
  2. 4.1.1 Global Food Allergy Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Food Allergy Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Food Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Food Allergy Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Food Allergy Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Food Allergy Therapeutics Players, Product Type & Application
  8. 4.5 Global Food Allergy Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Food Allergy Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Food Allergy Therapeutics Tier 1, Tier 2, and Tier 3
5 Food Allergy Therapeutics Market Size by Type
  1. 5.1 Global Food Allergy Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Food Allergy Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Food Allergy Therapeutics Revenue Market Share by Type (2021-2032)
6 Food Allergy Therapeutics Market Size by Application
  1. 6.1 Global Food Allergy Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Food Allergy Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Food Allergy Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aimmune Therapeutics
  2. 7.1.1 Aimmune Therapeutics Company Information
  3. 7.1.2 Aimmune Therapeutics Business Overview
  4. 7.1.3 Aimmune Therapeutics Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aimmune Therapeutics Food Allergy Therapeutics Product Portfolio
  6. 7.1.5 Aimmune Therapeutics Recent Developments
  7. 7.2 ALK Abello
  8. 7.2.1 ALK Abello Company Information
  9. 7.2.2 ALK Abello Business Overview
  10. 7.2.3 ALK Abello Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ALK Abello Food Allergy Therapeutics Product Portfolio
  12. 7.2.5 ALK Abello Recent Developments
  13. 7.3 Amneal Pharma
  14. 7.3.1 Amneal Pharma Company Information
  15. 7.3.2 Amneal Pharma Business Overview
  16. 7.3.3 Amneal Pharma Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Amneal Pharma Food Allergy Therapeutics Product Portfolio
  18. 7.3.5 Amneal Pharma Recent Developments
  19. 7.4 HUAPONT Pharm
  20. 7.4.1 HUAPONT Pharm Company Information
  21. 7.4.2 HUAPONT Pharm Business Overview
  22. 7.4.3 HUAPONT Pharm Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 HUAPONT Pharm Food Allergy Therapeutics Product Portfolio
  24. 7.4.5 HUAPONT Pharm Recent Developments
  25. 7.5 Kaleo
  26. 7.5.1 Kaleo Company Information
  27. 7.5.2 Kaleo Business Overview
  28. 7.5.3 Kaleo Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Kaleo Food Allergy Therapeutics Product Portfolio
  30. 7.5.5 Kaleo Recent Developments
  31. 7.6 Perrigo
  32. 7.6.1 Perrigo Company Information
  33. 7.6.2 Perrigo Business Overview
  34. 7.6.3 Perrigo Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Perrigo Food Allergy Therapeutics Product Portfolio
  36. 7.6.5 Perrigo Recent Developments
  37. 7.7 UCB Pharma
  38. 7.7.1 UCB Pharma Company Information
  39. 7.7.2 UCB Pharma Business Overview
  40. 7.7.3 UCB Pharma Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 UCB Pharma Food Allergy Therapeutics Product Portfolio
  42. 7.7.5 UCB Pharma Recent Developments
  43. 7.8 Viatris
  44. 7.8.1 Viatris Company Information
  45. 7.8.2 Viatris Business Overview
  46. 7.8.3 Viatris Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Viatris Food Allergy Therapeutics Product Portfolio
  48. 7.8.5 Viatris Recent Developments
  49. 7.9 Bayer
  50. 7.9.1 Bayer Company Information
  51. 7.9.2 Bayer Business Overview
  52. 7.9.3 Bayer Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bayer Food Allergy Therapeutics Product Portfolio
  54. 7.9.5 Bayer Recent Developments
  55. 7.10 GSK
  56. 7.10.1 GSK Company Information
  57. 7.10.2 GSK Business Overview
  58. 7.10.3 GSK Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GSK Food Allergy Therapeutics Product Portfolio
  60. 7.10.5 GSK Recent Developments
  61. 7.11 J & J
  62. 7.11.1 J & J Company Information
  63. 7.11.2 J & J Business Overview
  64. 7.11.3 J & J Food Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 J & J Food Allergy Therapeutics Product Portfolio
  66. 7.11.5 J & J Recent Developments
8 North America
  1. 8.1 North America Food Allergy Therapeutics Revenue (2021-2032)
  2. 8.2 North America Food Allergy Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Food Allergy Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Food Allergy Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Food Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Food Allergy Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Food Allergy Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Food Allergy Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Food Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Food Allergy Therapeutics Revenue by Country
  11. 8.6.1 North America Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Food Allergy Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Food Allergy Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Food Allergy Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Food Allergy Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Food Allergy Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Food Allergy Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Food Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Food Allergy Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Food Allergy Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Food Allergy Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Food Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Food Allergy Therapeutics Revenue by Country
  11. 9.6.1 Europe Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Food Allergy Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Food Allergy Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Food Allergy Therapeutics Revenue (2021-2032)
  2. 10.2 China Food Allergy Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Food Allergy Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Food Allergy Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Food Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Food Allergy Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Food Allergy Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Food Allergy Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Food Allergy Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Food Allergy Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Food Allergy Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Food Allergy Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Food Allergy Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Food Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Food Allergy Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Food Allergy Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Food Allergy Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Food Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Food Allergy Therapeutics Revenue by Country
  11. 11.6.1 Asia Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Food Allergy Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Food Allergy Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Food Allergy Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Food Allergy Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Food Allergy Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Food Allergy Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Food Allergy Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Food Allergy Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Food Allergy Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Food Allergy Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Food Allergy Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Food Allergy Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Food Allergy Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Food Allergy Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Food Allergy Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.